Dr. Mazumder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18000 Studebaker Rd
Ste 800
Cerritos, CA 90703Phone+1 562-735-3226
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1979 - 1983
- Baylor College of MedicineResidency, Internal Medicine, 1977 - 1979
- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
- CA State Medical License 2016 - 2026
- NY State Medical License 1998 - 2023
- DC State Medical License 1991 - 2013
- MD State Medical License 1979 - 1991
- TX State Medical License 1984 - 1986
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications Start of enrollment: 2016 Jan 01
Roles: Principal Investigator, Contact
- A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2020 Sep 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 304 citationsBortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therap...Radek Spisek, Anna Charalambous, Amitabha Mazumder, David H. Vesole, Sundar Jagannath
Blood. 2007-06-01 - 225 citationsEnhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implicationsDavid H. Chang, Nancy Liu, Virginia M. Klimek, Hani Hassoun, Amitabha Mazumder
Blood. 2006-07-15 - 27 citationsVorinostat plus bortezomib for the treatment of relapsed/refractory multiple myeloma: a case series illustrating utility in clinical practice.Amitabha Mazumder, David H. Vesole, Sundar Jagannath
Clinical Lymphoma, Myeloma & Leukemia. 2010-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: